scholarly journals Anxiety and depression in patients with obstructive ventilation disorders: the respect study. Part 2

2017 ◽  
Vol 21 (4) ◽  
pp. 15-20
Author(s):  
Elena A Andreeva ◽  
Marina A Pokhaznikova ◽  
Irina E Moiseeva ◽  
Olga Yu Kuznetsova ◽  
Jean-Marie Degryse

The article presents an analysis of the risk factors for anxiety and depression in people with airflow limitation based on the results of the second (diagnostic) phase of the RESPECT (RESearch on the PrEvalence and the diagnosis of COPD and its Tobacco-related aetiology). The data indicates that participants with airflow limitation that had been revealed during the epidemiological study and with borderline or abnormal anxiety and/or depression showed in diagnostic study persistent airflow limitation (FEV1/FVC = 66.48 ± 10.22, p < 0.05) and more perceived respiratory symptoms (CAT = 11.1 ± 10.01, mMRC = 1.68 ± 1.02, p < 0.001) compared to those without mental disorders. Also, they tended to have concomitant cardiovascular diseases (coronary heart disease, chronic heart failure, p < 0.001) and diabetes mellitus (p < 0.01) more frequently. Although chronic heart failure is the most prominent risk factor for anxiety/depression, it becomes non-significant when corrected for other somatic diseases and respiratory symptoms.

2007 ◽  
Vol 6 (1) ◽  
pp. 180-180
Author(s):  
S BOZINOVIC ◽  
A GRDINIC ◽  
D STAMENKOVIC ◽  
M STOJADINOVIC ◽  
I MARKOVIC ◽  
...  

2009 ◽  
Vol 5 (3) ◽  
pp. 171-184 ◽  
Author(s):  
Linuo Zhou ◽  
Wei Deng ◽  
Lixue Zhou ◽  
Ping Fang ◽  
Daikun He ◽  
...  

Author(s):  
Naila Niaz ◽  
Syed Muhammad Faraz Ali ◽  
Attaullah Younas ◽  
Tallat Anwar Faridi ◽  
Asif Hanif

Despite advancing medical technology, Heart Failure (HF) is still a prevalent disease with high mortality and high health expenditure. To improve patient outcome and prognosis, it is important to identify the association of risk factors which leads to the co-morbid depression and anxiety in heart failure patients. Objectives: To determine the association of depression and/or anxiety with age, gender and ejection fraction in heart failure patients. Methods: It is an analytical cross sectional study including 323 CHF patients who visited the to the Faisalabad Institute of Cardiology hospital Out-Patient Department, 250 were males and 73 were females, mean age was 54.1 ± 9.2 years having 70 years as maximum and 25 years as minimum.  Data collection was done using Hospital Anxiety and Depression Scale (HADS) questionnaire to assess depression and anxiety. Data was analyzed using SPSS version 24. For quantitative data, mean and standard deviation was calculated and for qualitative data frequency and percentages was calculated. To measure the association of anxiety and depression with age categories, ejection fraction and gender, chi square test was used. P values less than and equal to 0.05 were taken as significant. Results: No association of depression and anxiety with gender and Left Ventricular Ejection Fraction (LVEF) was observed. However, depression and anxiety were found to be significantly associated with age Conclusions: The study concluded that age is a strong risk factor of depression and anxiety in congestive heart failure patients. Multidisciplinary health care team approach and interventions are required to cater chronic heart failure (CHF) patients to address the psychological burden.


2019 ◽  
Vol 26 (4) ◽  
pp. 90-101 ◽  
Author(s):  
L. G. Voronkov ◽  
A.V. Liashenko ◽  
N. A. Tkach ◽  
L. P. Paraschenyuk

Regulatory, structural and functional disturbances of other organs and systems (kidney, hepar, vessels, skeletal muscles, brain etc) play the substantial role in CHF. These disturbances may be the conseguences of pre-existing states (hypertension, diabetes, hypo- or hyperthyreoidism etc) and from, other side, may reflect the progressive inherent changes in chronic heart failure (CHF) per se. In particular, currently relevant comorbidities in this syndrome are insulin resistance, diabetes mellitus, renal dysfunction, cognitive impairment, depression peripheral myopathy. Every of them demonstrate the close pathophysiologic interplay with CHF which results in clinical prognosis impairment and in decrease of life quality. Prevalence of renal dysfunction described in 39 % of patients with CHF in our research. Renal dysfunction connected with older age, high class of NYHA, diabetes mellitus, arterial hypertension, higher level of citrulline and uric acid in patients with CHF. Patients with iron deficiency characterized with high class of NYHA, low functionality and poor quality of life. In patients with iron deficiency noted high level of mortality and many critical clinical events. Prevalence of cognitive impairment described in 85 % of patients with CHF in our research. Cognitive dysfunction associated with older age, high class of NYHA, diabetes mellitus, arterial hypertension, bad life quality, high level of ceruloplasmin in patients with CHF. Taking to account above-mentioned comorbidities in quideline-recommended management of CHF and the use of additional therapeutic approaches targeted to its treatment represent the contemporary strategy of personalized treatment in this syndrome.


2021 ◽  
Vol 9 (11) ◽  
pp. 521-526
Author(s):  
A. Maliki Alaoui ◽  
◽  
Y. Fihri ◽  
A. Ben El Mekki ◽  
H. Bouzelmat ◽  
...  

Heart failure (HF) is a major public issue taking an epidemic dimension globally. Its incidence is continuing to rise because of a growing and aging population. We held a cross-sectional retrospective studyin the cardiology department of Mohamed V military teaching hospital of Rabat in morocco fromSeptember 2019 toSeptember 2021, including 104 patients admitted with HF. The mean age was 68.5 ±10.3year. Hypertension and diabetes mellitus are the most common risk factors. HF with reduced ejection fraction represents about 49%. Forty-four percent had dilated cardiomyopathy. Ischemic heart disease is the first cause of HF.


Sign in / Sign up

Export Citation Format

Share Document